osimertinib
astrazeneca
['lung', 'lcsm,(-blcsm)', 'osimertinib', 'nsclc', 'sclc']
adjuvant osimertinib improves survival in patients with resected egfr-mutated nsclc #lcsm #lungcancer #oncology #asco23
News and views from the world of clinical oncology and hematology